Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhang, Jing ^a   Wang, Chen ^b   Yu, Shuchun ^a   Luo, Zhenzhong ^a   Chen, Yong ^a   Liu, Qin ^a   Hua, Fuzhou ^a   Xu, Guohai ^a   Yu, Peng ^a  

^a NANCHANG UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHER DERIVATIVE; MTOR PROTEIN, RAT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SEVOFLURANE; TARGET OF RAPAMYCIN KINASE;

ANIMAL; APOPTOSIS; DRUG EFFECTS; HEART; HEART MUSCLE; ISCHEMIC POSTCONDITIONING; MALE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PROCEDURES; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; APOPTOSIS; HEART; ISCHEMIC POSTCONDITIONING; MALE; METHYL ETHERS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84922670918     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07317     Document Type: Article

References (55)

1. Zhang, Y. & Ren, J. Targeting autophagy for the therapeutic application of histone deacetylase inhibitors in ischemia/reperfusion heart injury. Circulation 129, 1088-1091 (2014).
2. Li, H. et al. Isoflurane postconditioning reduces ischemia-induced nuclear factorkappaB activation and interleukin 1beta production to provide neuroprotection in rats and mice. Neurobiol Dis 54, 216-224 (2013).
3. Lange, M. et al. Desflurane-induced postconditioning is mediated by betaadrenergic signaling: role of beta 1-and beta 2-adrenergic receptors, protein kinase A, and calcium/calmodulin-dependent protein kinase II. Anesthesiology 110, 516-528 (2009).
4. Larsen, J. R., Sivesgaard, K., Christensen, S. D., Honge, J. L. & Hasenkam, J. M. Heart rate limitation and cardiac unloading in sevoflurane post-conditioning. Acta Anaesthesiol Scand 56, 57-65 (2012).
5. Orriach, J. L. et al. Sevoflurane in intraoperative and postoperative cardiac surgery patients. Our experience in intensive care unit with sevoflurane sedation. Curr Pharm Des 19, 3996-4002 (2013).
6. Holaday, D. A. & Smith, F. R. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 54, 100-106 (1981).
7. Kloner, R. A. & Rezkalla, S. H. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res 70, 297-307 (2006).
8. Inamura, Y., Miyamae, M., Sugioka, S., Domae, N. & Kotani, J. Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia-reperfusion. J Anesth 24, 215-224 (2010).
9. Bader, A. G., Kang, S., Zhao, L. & Vogt, P. K. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5, 921-929 (2005).
10. Chen, H. T. et al. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts. Acta Pharmacol Sin 29, 931-941 (2008).
11. Drenger, B. et al. Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3-and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology 114, 1364-1372 (2011).
12. Stumpner, J. et al. The Role of Cyclooxygenase-1 and-2 in Sevoflurane-Induced Postconditioning Against Myocardial Infarction. Semin Cardiothorac Vasc Anesth 18, 272-280 (2014).
13. Engelman, J. A., Luo, J. & Cantley, L. C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7, 606-619 (2006).
14. Fry, M. J. Structure, regulation and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1226, 237-268 (1994).
15. Cuadrado, I., Fernandez-Velasco, M., Bosca, L. & de Las Heras, B. Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation. Cell Death Dis 2, e229 (2011).
16. Aoyagi, T. et al. Cardiac mTOR protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 303, H75-85 (2012).
17. Santulli, G.&Totary-Jain, H. Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics 14, 1517-1526 (2013).
18. Wilson, T. R. et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 487, 505-509 (2012).
19. Fallahi-Sichani, M., Honarnejad, S., Heiser, L. M., Gray, J. W. & Sorger, P. K. Metrics other than potency reveal systematic variation in responses to cancer drugs. Nat Chem Biol 9, 708-714 (2013).
20. Luedde, M. et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res 103, 206-216 (2014).
21. Neubauer, S. The failing heart-an engine out of fuel.NEngl JMed 356, 1140-1151 (2007).
22. Neubauer, S. et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96, 2190-2196 (1997).
23. Pham, T., Loiselle, D., Power, A. & Hickey, A. J. Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart. Am J Physiol Cell Physiol 307, C499-507 (2014).
24. Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309-1312 (1998).
25. Nieminen, A. I. et al.Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis. Proc Natl Acad Sci USA 110, E1839-1848 (2013).
26. Liang, J. et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9, 218-224 (2007).
27. Zhu, M. et al. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res 72, 152-162 (2006).
28. Rahman, S. et al. Phosphorylation of GSK-3beta mediates intralipid-induced cardioprotection against ischemia/reperfusion injury. Anesthesiology 115, 242-253 (2011).
29. Li, L. et al. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway. Biochimie 103, 89-100 (2014).
30. Janku, F., Kaseb, A. O., Tsimberidou, A. M., Wolff, R. A. & Kurzrock, R. Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 5, 3012-3022 (2014).
31. Obal, D. et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 87, 905-911 (2001).
32. Rodŕguez-González, R. et al. Effects of sevoflurane postconditioning on cell death, inflammation and TLR expression in human endothelial cells exposed to LPS. J Transl Med 11, 87 (2013).
33. Carreira, R. S., Lee, P. & Gottlieb, R. A. Mitochondrial therapeutics for cardioprotection. Curr Pharm Des 17, 2017-2035 (2011).
34. Doenst, T., Nguyen, T. D. & Abel, E. D. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res 113, 709-724 (2013).
35. Inoki, K., Zhu, T. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590 (2003).
36. Lamberts, R. R. et al. Reactive oxygen species-induced stimulation of 59AMPactivated protein kinase mediates sevoflurane-induced cardioprotection. Circulation 120, S10-15 (2009).
37. Zhao, J. et al. Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition. Circulation 128, S121-129 (2013).
38. Perino, A. et al. Integrating Cardiac PIP 3and cAMP Signaling through a PKA Anchoring Function of p110c. Mol Cell 42, 84-95 (2011).
39. Gioran, A., Nicotera, P. & Bano, D. Impaired mitochondrial respiration promotes dendritic branching via the AMPK signaling pathway. Cell Death Dis 5, e1175 (2014).
40. Fumarola, C., Bonelli, M. A., Petronini, P. G. Alfieri, R. R. Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochem Pharmacol 90, 197-207 (2014).
41. Tasian, S. K., Teachey, D. T. & Rheingold, S. R. Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies. Front Oncol 4, 108 (2014).
42. Zhang, L., Wang, H., Xu, J., Zhu, J. & Ding, K. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Toxicol Lett 228, 248-259 (2014).
43. Cantley, L. C. The phosphoinositide 3-kinase pathway. Science 296, 1655-1657 (2002).
44. Darling, C. E. et al. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 289, H1618-1626 (2005).
45. Park, S. S., Zhao, H., Mueller, R. A. & Xu, Z. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol 40, 708-716 (2006).
46. Schwartz, L. M. & Lagranha, C. J. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemiareperfusion injury in pigs. Am J Physiol Heart Circ Physiol. 290, H1011-1018 (2006).
47. Maiese, K., Chong, Z. Z., Shang, Y. C. & Wang, S. Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets 16, 1203-1214 (2012).
48. Zinkel, S., Gross, A.& Yang, E. BCL2 family inDNAdamage and cell cycle control. Cell Death Differ 13, 1351-1359 (2006).
49. Wang, C. et al. Extracellular signal-regulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesth Analg 103, 281-288 (2006).
50. Qiao, S. et al. Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-kappaB and upregulation of autophagy. J Anesth 27, 251-260 (2013).
51. Varadarajan, S. G., An, J., Novalija, E. & Stowe, D. F. Sevoflurane before or after ischemia improves contractile and metabolic function while reducing myoplasmic Ca(21) loading in intact hearts. Anesthesiology 96, 125-133 (2002).
52. Liao, R., Podesser, B. K. & Lim, C. C. The continuing evolution of the Langendorff and ejecting murine heart: new advances in cardiac phenotyping. Am J Physiol Heart Circ Physiol 303, H156-167 (2012).
53. Zhang, X. et al. Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension 55, 1412-1417 (2010).
54. Kordas, K. S. et al. ATP and ATPase secretion by exocrine pancreas in rat, guinea pig, and human. Pancreas 29, 53-60 (2004).
55. Wang, D., Malo, D. & Hekimi, S. Elevated mitochondrial reactive oxygen species generation affects the immune response via hypoxia-inducible factor-1alpha in long-lived Mclk11/2 mouse mutants. J Immunol 184, 582-590 (2010).